Header cover image
  • Investing Ideas
  • Mexican Software Transformative Artificial intelligence (AI) Healthcare Stocks

Mexican Software Transformative Artificial intelligence (AI) Healthcare Stocks

Results

130

4 new

Artificial intelligence (AI) is set to transform healthcare by enhancing diagnostics, personalizing medicine, boosting operational efficiency, expanding remote care, and accelerating research. AI outperforms humans in detecting diseases like cancer from scans, tailors treatments using genetic and lifestyle data, and streamlines hospital workflows with tools like predictive analytics and automated transcription. It powers telemedicine, monitors chronic conditions in real-time, and speeds up drug discovery by analyzing vast datasets for insights into complex diseases. Despite challenges like data privacy, bias, and integration costs, AI’s ability to improve accuracy, access, and affordability could save billions and extend lives, marking a seismic shift in healthcare delivery and outcomes.

130 companies

Shenzhen Bioeasy Biotechnology

Market Cap: CN¥2.7b

Provides rapid food safety testing reagents and instruments in China and internationally.

300942

CN¥6.72

7D

-2.0%

1Y

-47.9%

SG HealthCare

Market Cap: ₩211.8b

Provides medical diagnostic equipment.

A398120

₩1,939.00

7D

-9.2%

1Y

-38.1%

INFINITT Healthcare

Market Cap: ₩227.2b

Engages in medical imaging information solution software business.

A071200

₩9,320.00

7D

-11.1%

1Y

50.1%

Acer Medical

Market Cap: NT$1.4b

Offers artificial intelligence, clinical data, and software for healthcare sector.

6857

NT$91.00

7D

-1.1%

1Y

-20.2%

IGC Pharma

Market Cap: US$28.7m

A clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer’s disease in the United States and Colombia.

IGC

US$0.31

7D

3.4%

1Y

-15.6%

Pharos iBio

Market Cap: ₩65.9b

Engages in the development of treatments for rare and refractory diseases using AI based drug development platform in South Korea.

A388870

₩5,090.00

7D

-10.2%

1Y

-8.9%

Renascience

Market Cap: JP¥17.9b

Develops and sells pharmaceuticals, medical devices, and artificial intelligence (AI)-powered programmed medical devices in Japan.

New

4889

JP¥1,302.00

7D

8.4%

1Y

-43.1%

Imaging Biometrics

Market Cap: UK£1.7m

Provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, China, the European Union, South America, Australia, and the United States.

IBAI

UK£0.006

7D

-14.3%

1Y

0%

Yoda Pharmaceuticals

Market Cap: NT$3.8b

An AI-driven company, focuses on development of drugs targeting central nervous system disorders.

7829

NT$46.55

7D

3.6%

1Y

22.5%

Syra Health

Market Cap: US$14.8m

A healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education and training, and healthcare workforce development and staffing in the United States.

SYRA

US$0.78

7D

-13.3%

1Y

1,071.2%

NanoEntek

Market Cap: ₩138.7b

Engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally.

A039860

₩3,640.00

7D

-9.7%

1Y

2.1%

UBC Medical Indonesia

Market Cap: Rp671.5b

Distributes medical devices in Indonesia.

LABS

Rp170.00

7D

1.2%

1Y

20.6%

INTAI Technology

Market Cap: NT$7.2b

Produces and sells medical devices and precision fasteners.

4163

NT$142.00

7D

1.4%

1Y

34.0%

Zhejiang Taimei Medical Technology

Market Cap: HK$3.1b

Zhejiang Taimei Medical Technology Co., Ltd.

2576

HK$5.55

7D

-2.1%

1Y

10.9%

Cowealth Medical ChinaLtd

Market Cap: CN¥4.7b

Operates as a medical company in China.

603122

CN¥11.85

7D

-4.8%

1Y

64.8%

Rocket One

Market Cap: US$14.4m

Focuses on developing and commercializing AI semiconductor infrastructure.

RKTO

US$0.75

7D

-2.4%

1Y

-42.7%

Onyx Healthcare

Market Cap: NT$3.7b

A professional medical IT company, engages in the design, manufacture, and trade of medical computers and peripherals for hospital/clinical IT market in Taiwan, the United States, and internationally.

6569

NT$93.50

7D

1.1%

1Y

-16.9%

Ginkgo Bioworks Holdings

Market Cap: US$468.7m

Develops a platform for cell engineering in the United States.

New

DNA

US$7.40

7D

9.0%

1Y

-41.0%

European Medical Solutions

Market Cap: €14.4m

Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium and internationally.

ALEMS

€3.40

7D

-15.0%

1Y

-27.7%

DIAGNOS

Market Cap: CA$46.7m

Provides software-based services for healthcare sector in Canada, the United States, Mexico, and internationally.

ADK

CA$0.39

7D

4.0%

1Y

50.0%

iBio

Market Cap: US$73.0m

A preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space.

IBIO

US$1.43

7D

0%

1Y

80.8%

AIxCrypto Holdings

Market Cap: US$23.8m

Focuses on building an ecosystem that integrates artificial intelligence and blockchain while bridging Web2 and Web3.

New

AIXC

US$1.12

7D

65.4%

1Y

-39.8%

Page 4 of 4